AI assistant
Sending…
Replimune Group, Inc. — Director's Dealing 2018
Jul 20, 2018
33193_dirs_2018-07-19_1cb478f5-7cb6-49f3-a4d5-8b4a82cc1313.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2018-07-19
Reporting Person: Coffin Robert (Director, President and C.E.O., 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2412118 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $3.30 | 2027-07-26 | Common Stock (318299) | Direct |
Footnotes
F1: 25% of the shares underlying this stock option vest on July 26, 2018 and the remainder of the shares underlying this stock option vest in 36 equal monthly installments thereafter.
More from Replimune Group, Inc.
Director's Dealing
2026
Feb 20
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Regulatory Filings
2026
Jan 12
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19